Gilbert Nadeau
- Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classificationBy Paul W. Jones, Lukasz Adamek, Gilbert Nadeau and Norbert BanikPaul W. Jones1Division of Clinical Science, St George's University of London, LondonLukasz Adamek2Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, UKGilbert Nadeau2Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, UKNorbert Banik3Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany
- Novel study design to assess the utility of the COPD assessment test (CAT)By Kevin Gruffydd-Jones, Helen Pearce, Steve Holmes, Peter Kardos, Roger Escamila, Roberto Dal Negro, June Roberts, Gilbert Nadeau, David Leather and Paul JonesKevin Gruffydd-Jones1Box Surgery, Box, Corsham, United KingdomHelen Pearce2Respiratory Centre of Excellence, GlaxoSmithKline, London, United KingdomSteve Holmes3Park Road Surgery, Shepton Mallet, Somerset, United KingdomPeter Kardos4Gemeinschaftspraxis und Zentrum für Pneumologie, Allergologie, Schlafmedizin, Klinik Maingau, Frankfurt, GermanyRoger Escamila5Service de Pneumologie, Hôpital Larrey- CHU Toulouse, Toulouse, FranceRoberto Dal Negro6Divisione di Pneumologia, Ospedale Civile Orlandi di Bussolengo, Bussolengo, Verona, ItalyJune Roberts7Clinical Sciences Building, Salford Royal Hospital Foundation Trust, Salford, United KingdomGilbert Nadeau2Respiratory Centre of Excellence, GlaxoSmithKline, London, United KingdomDavid Leather2Respiratory Centre of Excellence, GlaxoSmithKline, London, United KingdomPaul Jones8Clincial Sciences, St George's University of London, London, United Kingdom
- Comparison of modified Medical Research Council (mMRC) dyspnoea scale cut point ≥1 with COPD assessment test (CAT) ≥10 to differentiate low and high symptom COPD patientsBy Paul Jones, Lukasz Adamek, Gilbert Nadeau and Norbert BanikPaul Jones1Clinical Science, St. George's University, London, United KingdomLukasz Adamek2Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomGilbert Nadeau2Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomNorbert Banik3Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany
- Comparison of quality of life scores with modified Medical Research Council (mMRC) dyspnoea scale using data from the European health-related quality of life studyBy Paul Jones, Lukasz Adamek, Gilbert Nadeau and Norbert BanikPaul Jones1Clinical Science, St. George's University, London, United KingdomLukasz Adamek2Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomGilbert Nadeau2Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomNorbert Banik3Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany
- GOLD 2011: Combined COPD assessment of patients from the European health-related quality of life studyBy Lukasz Adamek, Paul Jones, Gilbert Nadeau and Norbert BanikLukasz Adamek1Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomPaul Jones2Clinical Science, St. George's, University of London, London, United KingdomGilbert Nadeau1Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomNorbert Banik3Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany
- Prevalence and under-diagnosis of airflow limitation and other lung function abnormalities in patients with ischaemic heart disease: an interim analysis of the ALICE studyBy Joan Soriano, Nicolas Roche, John Cockcroft, Klaus Rabe, Mark Kearney, Guy Brusselle, Frits Franssen, Francisco Garcia Rio, Bo Lundbäck, Helen Marsden, Hana Muellerova, Paul Bloomfield, Gilbert Nadeau, Mathieu Vasselle, Zoe Adams, Angus Henderson and Leo FabbriJoan Soriano1Fundación Caubet-CIMERA Illes Balears, CIMERA, Bunyola, SpainNicolas Roche3Respiratory and Intensive Care Medicine, Hôtel-Dieu Hospital, University Paris Descartes, Paris, FranceJohn Cockcroft4Wales Heart Research Institute, Cardiff University School of Medicine, Cardiff, United KingdomKlaus Rabe9Department of Medicine, University Kiel, GermanyMark Kearney7Multidisciplinary Cardiovascular Research Centre, University of Leeds Medical School, United KingdomGuy Brusselle5Department of Respiratory Medicine, Ghent University Hospital, Ghent, BelgiumFrits Franssen2Program Development Centre, CIRO, Horn, NetherlandsFrancisco Garcia Rio11Hospital La Paz, IdiPAZ, Madrid, SpainBo Lundbäck8Dept of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, SwedenHelen Marsden10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomHana Muellerova10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomPaul Bloomfield10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomGilbert Nadeau10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomMathieu Vasselle12Excellence Medicale, GSK France, Marly Le Roi, FranceZoe Adams10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomAngus Henderson10Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomLeo Fabbri6Department of Oncology Haematology and Respiratory Diseases, Section of Respiratory Diseases, University of Modena & Reggio Emilia, Modena, Italy
- The burden of non-communicable lung disease in urban MalawiBy Kevin Mortimer, Hadia Azhar, Jaymini Patel, Sabrina Kapur, Louisa Gnatiuc, Peter Burney, Kourtney Davis, Gilbert Nadeau, Moffat Nyirenda and Stephen GordonKevin Mortimer1Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United KingdomHadia Azhar2National Heart and Lung Institute, Imperial College, London, United KingdomJaymini Patel2National Heart and Lung Institute, Imperial College, London, United KingdomSabrina Kapur2National Heart and Lung Institute, Imperial College, London, United KingdomLouisa Gnatiuc2National Heart and Lung Institute, Imperial College, London, United KingdomPeter Burney2National Heart and Lung Institute, Imperial College, London, United KingdomKourtney Davis3Worldwide Epidemiology, GSK, Wavre, BelgiumGilbert Nadeau3Worldwide Epidemiology, GSK, Wavre, BelgiumMoffat Nyirenda4Malawi Epidemiology and Intervention Research Unit, London School of Hygiene and Tropical Medicine, London, United KingdomStephen Gordon2National Heart and Lung Institute, Imperial College, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.